Identification of patent foramen ovale permitting paradoxic embolism

Department of Internal Medicine, Hannover Medical School, Germany.

OBJECTIVES. We sought to analyze the morphologic and functional characteristics of the patent foramen ovale in patients with different clinical likelihoods for paradoxic embolism. BACKGROUND. The incidence of patent foramen ovale is increased in patients with otherwise unexplained arterial ischemic events. Because signs of venous thrombosis are absent in most patients, the diagnosis of paradoxic embolism is often questioned, even when patent foramen ovale is the only potential explanation for the ischemic event. METHODS. Seventy-eight patients with a patent foramen ovale detected by contrast transesophageal echocardiography were studied: 21 patients with an otherwise unexplained arterial ischemic event and clinical evidence implying paradoxic embolism (group I), 30 patients with an unexplained ischemic event but no clinical evidence for paradoxic embolism (group II) and 27 patients without an ischemic event (group III). RESULTS. During transesophageal contrast echocardiography, patients in group I had more severe right to left shunting (mean +/- SD 52 +/- 16% of the left atrial area filled with contrast medium) and a wider opening of the patent foramen ovale (7.1 +/- 3.6-mm separation between the septum primum and the septum secundum) than did patients in group II (35 +/- 15% and 4.4 +/- 3.2 mm, respectively, p < 0.001) or group III (23 +/- 12% and 3.0 +/- 2.0 mm, respectively, p < 0.001). The incidence of atrial septal aneurysm was similar in the three groups. Severe contrast shunting (> or = 50% of the left atrial area filled with contrast medium) and wide opening of the patent foramen ovale (> or = 5-mm separation) revealed a high sensitivity (71% and 86%, respectively) and high specificity (86% and 96%, respectively) for identification of group I patients. CONCLUSIONS. Right to left contrast shunting is more severe and opening of the patent foramen ovale is larger in patients with ischemic arterial events considered to be due to paradoxic embolism. In patients with a patent foramen ovale as the only potential cause for ischemic events and no signs of venous thrombosis, morphologic and functional variables assessed by transesophageal echocardiography may be helpful in estimating the likelihood of paradoxic embolism.

This article has been cited by other articles:

				R. K. Mareedu, M. S. Shah, J. E. Mesa, and C. S. McCauley Percutaneous Closure of Patent Foramen Ovale: A Case Series and Literature Review Clin. Med. Res., December 1, 2007; 5(4): 218 - 226. [Abstract] [Full Text] [PDF]

				O. I.I. Soliman, M. L. Geleijnse, F. J. Meijboom, A. Nemes, O. Kamp, P. Nihoyannopoulos, N. Masani, S. B. Feinstein, and F. J. Ten Cate The use of contrast echocardiography for the detection of cardiac shunts Eur J Echocardiogr, June 1, 2007; 8(3): s2 - s12. [Abstract] [Full Text] [PDF]

				M. R. Di Tullio, R. L. Sacco, R. R. Sciacca, Z. Jin, and S. Homma Patent Foramen Ovale and the Risk of Ischemic Stroke in a Multiethnic Population J. Am. Coll. Cardiol., February 20, 2007; 49(7): 797 - 802. [Abstract] [Full Text] [PDF]

				A. Harloff, M. Handke, M. Reinhard, A. Geibel, and A. Hetzel Therapeutic Strategies After Examination by Transesophageal Echocardiography in 503 Patients With Ischemic Stroke Stroke, March 1, 2006; 37(3): 859 - 864. [Abstract] [Full Text] [PDF]

				H. Hara, R. Virmani, E. Ladich, S. Mackey-Bojack, J. Titus, M. Reisman, W. Gray, M. Nakamura, M. Mooney, A. Poulose, et al. Patent Foramen Ovale: Current Pathology, Pathophysiology, and Clinical Status J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1768 - 1776. [Abstract] [Full Text] [PDF]

				S. Homma and R. L. Sacco Patent Foramen Ovale and Stroke Circulation, August 16, 2005; 112(7): 1063 - 1072. [Full Text] [PDF]

				S. Windecker, A. Wahl, K. Nedeltchev, M. Arnold, M. Schwerzmann, C. Seiler, H. P. Mattle, and B. Meier Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke J. Am. Coll. Cardiol., August 18, 2004; 44(4): 750 - 758. [Abstract] [Full Text] [PDF]

				L. A. Wu, J. F. Malouf, J. A. Dearani, D. J. Hagler, G. S. Reeder, G. W. Petty, and B. K. Khandheria Patent Foramen Ovale in Cryptogenic Stroke: Current Understanding and Management Options Arch Intern Med, May 10, 2004; 164(9): 950 - 956. [Abstract] [Full Text] [PDF]

				S. Homma, R. L. Sacco, M. R. Di Tullio, R. R. Sciacca, J. P. Mohr, and PICSS Investigators Atrial anatomy in non-cardioembolic stroke patients: Effect of medical therapy J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1066 - 1072. [Abstract] [Full Text] [PDF]

				T. Walles, S. Fischer, M. Struber, and A. Haverich Paradoxic aortic arch embolization with occlusion of the supraaortic arteries Eur. J. Cardiothorac. Surg., September 1, 2002; 22(3): 448 - 449. [Abstract] [Full Text] [PDF]

				D. W. Droste, S. Lakemeier, T. Wichter, J. Stypmann, R. Dittrich, M. Ritter, M. Moeller, M. Freund, and E. B. Ringelstein Optimizing the Technique of Contrast Transcranial Doppler Ultrasound in the Detection of Right-to-Left Shunts Stroke, September 1, 2002; 33(9): 2211 - 2216. [Abstract] [Full Text] [PDF]

				M Strandberg, R J Marttila, H Helenius, and J Hartiala Transoesophageal echocardiography in selecting patients for anticoagulation after ischaemic stroke or transient ischaemic attack J. Neurol. Neurosurg. Psychiatry, July 1, 2002; 73(1): 29 - 33. [Abstract] [Full Text] [PDF]

				S. Homma, R. L. Sacco, M. R. Di Tullio, R. R. Sciacca, J.P. Mohr, and for the PFO in Cryptogenic Stroke Study (PICSS) In Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale: Patent Foramen Ovale in Cryptogenic Stroke Study Circulation, June 4, 2002; 105(22): 2625 - 2631. [Abstract] [Full Text] [PDF]

				J.-L. Mas, C. Arquizan, C. Lamy, M. Zuber, L. Cabanes, G. Derumeaux, J. Coste, and the Patent Foramen Ovale and Atrial Septal Aneurys Recurrent Cerebrovascular Events Associated with Patent Foramen Ovale, Atrial Septal Aneurysm, or Both N. Engl. J. Med., December 13, 2001; 345(24): 1740 - 1746. [Abstract] [Full Text] [PDF]

				M. Rachko, A. M. Safi, D. Yeshou, N. Pillai, L. Salciccioli, and R. A. Stein Cryptogenic Ischemic Stroke and Paradoxical Embolism: Should A Patent Foramen Ovale Be Closed?: Case Report and Literature Review Angiology, November 1, 2001; 52(11): 793 - 799. [Abstract] [PDF]

				C.-A. Greim, H. Trautner, K. Kramer, P. Zimmermann, C. C. Apfel, and N. Roewer The Detection of Interatrial Flow Patency in Awake and Anesthetized Patients: A Comparative Study Using Transnasal Transesophageal Echocardiography Anesth. Analg., May 1, 2001; 92(5): 1111 - 1116. [Abstract] [Full Text] [PDF]

				A. Franke and P. Hanrath The role of atrial septal abnormalities in cryptogenic stroke -- still questionable? Eur. Heart J., February 1, 2001; 22(3): 198 - 200. [PDF]

				A. J. Kerr, T. Buck, K. Chia, C. M. Chow, E. Fox, R. A. Levine, and M. H. Picard Transmitral Doppler: a new transthoracic contrast method for patent foramen ovale detection and quantification J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1959 - 1966. [Abstract] [Full Text] [PDF]

				S. De Castro, D. Cartoni, M. Fiorelli, M. Rasura, A. Anzini, E. M. Zanette, M. Beccia, C. Colonnese, F. Fedele, C. Fieschi, et al. Morphological and Functional Characteristics of Patent Foramen Ovale and Their Embolic Implications Stroke, October 1, 2000; 31(10): 2407 - 2413. [Abstract] [Full Text] [PDF]

				S. Windecker, A. Wahl, T. Chatterjee, A. Garachemani, F. R. Eberli, C. Seiler, and B. Meier Percutaneous Closure of Patent Foramen Ovale in Patients With Paradoxical Embolism : Long-Term Risk of Recurrent Thromboembolic Events Circulation, February 29, 2000; 101(8): 893 - 898. [Abstract] [Full Text] [PDF]

				H. P. Kuhl, R. Hoffmann, M. W. Merx, A. Franke, C. Klotzsch, W. Lepper, T. Reineke, J. Noth, and P. Hanrath Transthoracic echocardiography using second harmonic imaging: Diagnostic alternative to transesophageal echocardiography for the detection of atrial right to left shunt in patients with cerebral embolic events J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1823 - 1830. [Abstract] [Full Text] [PDF]

				J CHAMBERS Should percutaneous devices be used to close a patent foramen ovale after cerebral infarction or TIA? Heart, November 1, 1999; 82(5): 537 - 538. [Full Text]

				B.-W. Zhao, T.-C. Xian, H. Matsuo, and K. Mizushige Incidence and Clinical Significance of Interatrial Shunting in Patients with Atrial Septal Aneurysm Detected by Contrast Transesophageal Echocardiography Angiology, September 1, 1999; 50(9): 745 - 753. [Abstract] [PDF]

				K P Walsh, P T Wilmshurst, and W L Morrison Transcatheter closure of patent foramen ovale using the Amplatzer septal occluder to prevent recurrence of neurological decompression illness in divers Heart, March 1, 1999; 81(3): 257 - 261. [Abstract] [Full Text]

				P. WILMSHURST Cardiovascular problems in divers Heart, December 1, 1998; 80(6): 537 - 538. [Full Text]

				S. Homma, M. R. Di Tullio, R. L. Sacco, R. R. S. , C. Smith, and J. P. Mohr Surgical Closure of Patent Foramen Ovale in Cryptogenic Stroke Patients Stroke, December 1, 1997; 28(12): 2376 - 2381. [Abstract] [Full Text]